Literature DB >> 24567370

Simultaneous gene editing by injection of mRNAs encoding transcription activator-like effector nucleases into mouse zygotes.

Chunliang Li1, Rong Qi, Rebecca Singleterry, Judith Hyle, Amanda Balch, Xiuling Li, Jack Sublett, Hartmut Berns, Marcus Valentine, Virginia Valentine, Charles J Sherr.   

Abstract

Injection of transcription activator-like effector nucleases (TALEN) mRNAs into mouse zygotes transferred into foster mothers efficiently generated founder mice with heritable mutations in targeted genes. Immunofluorescence visualization of phosphorylated histone 2A (γH2AX) combined with fluorescence in situ hybridization revealed that TALEN pairs targeting the Agouti locus induced site-directed DNA breaks in zygotes within 6 h of injection, an activity that continued at reduced efficiency in two-cell embryos. TALEN-Agouti mRNAs injected into zygotes of brown FvB × C57BL/6 hybrid mice generated completely black pups, confirming that mutations were induced prior to, and/or early after, cell division. Founder mice, many of which were mosaic, transmitted altered Agouti alleles to F1 pups to yield an allelic series of mutant strains. Although mutations were targeted to "spacer" sequences flanked by TALEN binding sites, larger deletions that extended beyond the TALEN-binding sequences were also detected and were similarly inherited through the germ line. Zygotic coinjection of TALEN mRNAs directed to the Agouti, miR-205, and the Arf tumor suppressor loci yielded pups containing frequent and heritable mutations of two or three genes. Simultaneous gene editing in zygotes affords an efficient approach for producing mice with compound mutant phenotypes, bypassing constraints of conventional mouse knockout technology in embryonic stem cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24567370      PMCID: PMC3993595          DOI: 10.1128/MCB.00023-14

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  47 in total

1.  Molecular characterization of the mouse agouti locus.

Authors:  S J Bultman; E J Michaud; R P Woychik
Journal:  Cell       Date:  1992-12-24       Impact factor: 41.582

2.  Regulation of selected genome loci using de novo-engineered transcription activator-like effector (TALE)-type transcription factors.

Authors:  Robert Morbitzer; Patrick Römer; Jens Boch; Thomas Lahaye
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-24       Impact factor: 11.205

Review 3.  TAL effectors: customizable proteins for DNA targeting.

Authors:  Adam J Bogdanove; Daniel F Voytas
Journal:  Science       Date:  2011-09-30       Impact factor: 47.728

Review 4.  TAL effectors are remote controls for gene activation.

Authors:  Heidi Scholze; Jens Boch
Journal:  Curr Opin Microbiol       Date:  2011-01-05       Impact factor: 7.934

5.  A transcription activator-like effector toolbox for genome engineering.

Authors:  Neville E Sanjana; Le Cong; Yang Zhou; Margaret M Cunniff; Guoping Feng; Feng Zhang
Journal:  Nat Protoc       Date:  2012-01-05       Impact factor: 13.491

6.  Functional identification of optimized RNAi triggers using a massively parallel sensor assay.

Authors:  Christof Fellmann; Johannes Zuber; Katherine McJunkin; Kenneth Chang; Colin D Malone; Ross A Dickins; Qikai Xu; Michael O Hengartner; Stephen J Elledge; Gregory J Hannon; Scott W Lowe
Journal:  Mol Cell       Date:  2011-02-25       Impact factor: 17.970

7.  A pipeline for the generation of shRNA transgenic mice.

Authors:  Lukas E Dow; Prem K Premsrirut; Johannes Zuber; Christof Fellmann; Katherine McJunkin; Cornelius Miething; Youngkyu Park; Ross A Dickins; Gregory J Hannon; Scott W Lowe
Journal:  Nat Protoc       Date:  2012-02-02       Impact factor: 13.491

8.  Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting.

Authors:  Tomas Cermak; Erin L Doyle; Michelle Christian; Li Wang; Yong Zhang; Clarice Schmidt; Joshua A Baller; Nikunj V Somia; Adam J Bogdanove; Daniel F Voytas
Journal:  Nucleic Acids Res       Date:  2011-04-14       Impact factor: 16.971

9.  Genetic engineering of human pluripotent cells using TALE nucleases.

Authors:  Dirk Hockemeyer; Haoyi Wang; Samira Kiani; Christine S Lai; Qing Gao; John P Cassady; Gregory J Cost; Lei Zhang; Yolanda Santiago; Jeffrey C Miller; Bryan Zeitler; Jennifer M Cherone; Xiangdong Meng; Sarah J Hinkley; Edward J Rebar; Philip D Gregory; Fyodor D Urnov; Rudolf Jaenisch
Journal:  Nat Biotechnol       Date:  2011-07-07       Impact factor: 54.908

10.  A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity.

Authors:  Claudio Mussolino; Robert Morbitzer; Fabienne Lütge; Nadine Dannemann; Thomas Lahaye; Toni Cathomen
Journal:  Nucleic Acids Res       Date:  2011-08-03       Impact factor: 16.971

View more
  10 in total

1.  Small mitochondrial Arf (smArf) protein corrects p53-independent developmental defects of Arf tumor suppressor-deficient mice.

Authors:  Jolieke G van Oosterwijk; Chunliang Li; Xue Yang; Joseph T Opferman; Charles J Sherr
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-26       Impact factor: 11.205

Review 2.  TALEN-mediated genome engineering to generate targeted mice.

Authors:  Daniel Sommer; Annika E Peters; Ann-Kathrin Baumgart; Marc Beyer
Journal:  Chromosome Res       Date:  2015-02       Impact factor: 5.239

3.  Establishment of a tagged variant of Lgr4 receptor suitable for functional and expression studies in the mouse.

Authors:  Vitezslav Kriz; Michaela Krausova; Petra Buresova; Jan Dobes; Dusan Hrckulak; Olga Babosova; Jiri Svec; Vladimir Korinek
Journal:  Transgenic Res       Date:  2017-06-20       Impact factor: 2.788

4.  Mouse medulloblastoma driven by CRISPR activation of cellular Myc.

Authors:  BaoHan T Vo; Jin Ah Kwon; Chunliang Li; David Finkelstein; Beisi Xu; Brent A Orr; Charles J Sherr; Martine F Roussel
Journal:  Sci Rep       Date:  2018-06-07       Impact factor: 4.379

Review 5.  How mRNA therapeutics are entering the monoclonal antibody field.

Authors:  Lien Van Hoecke; Kenny Roose
Journal:  J Transl Med       Date:  2019-02-22       Impact factor: 5.531

6.  Anephrogenic phenotype induced by SALL1 gene knockout in pigs.

Authors:  Masahito Watanabe; Kazuaki Nakano; Ayuko Uchikura; Hitomi Matsunari; Sayaka Yashima; Kazuhiro Umeyama; Shuko Takayanagi; Tetsushi Sakuma; Takashi Yamamoto; Sumiyo Morita; Takuro Horii; Izuho Hatada; Ryuichi Nishinakamura; Hiromitsu Nakauchi; Hiroshi Nagashima
Journal:  Sci Rep       Date:  2019-05-29       Impact factor: 4.379

7.  Generation of outbred Ace2 knockout mice by RNA transfection of TALENs displaying colitis reminiscent pathophysiology and inflammation.

Authors:  Chuxin Liu; Liping Xiao; Feida Li; Huanhuan Zhang; Qin Li; Huan Liu; Shujin Fu; Chao Li; Xingju Zhang; Jun Wang; Nicklas H Staunstrup; Yong Li; Huanming Yang
Journal:  Transgenic Res       Date:  2014-12-02       Impact factor: 2.788

8.  TALEN-mediated genetic tailoring as a tool to analyze the function of acquired mutations in multiple myeloma cells.

Authors:  X Wu; P R Blackburn; R C Tschumper; S C Ekker; D F Jelinek
Journal:  Blood Cancer J       Date:  2014-05-09       Impact factor: 11.037

9.  Multi-reporter selection for the design of active and more specific zinc-finger nucleases for genome editing.

Authors:  Benjamin L Oakes; Danny F Xia; Elizabeth F Rowland; Denise J Xu; Irina Ankoudinova; Jennifer S Borchardt; Lei Zhang; Patrick Li; Jeffrey C Miller; Edward J Rebar; Marcus B Noyes
Journal:  Nat Commun       Date:  2016-01-07       Impact factor: 14.919

10.  Gene editing of the multi-copy H2A.B gene and its importance for fertility.

Authors:  Nur Diana Anuar; Sebastian Kurscheid; Matt Field; Lei Zhang; Edward Rebar; Philip Gregory; Thierry Buchou; Josephine Bowles; Peter Koopman; David J Tremethick; Tatiana A Soboleva
Journal:  Genome Biol       Date:  2019-01-31       Impact factor: 13.583

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.